Short interfering rna as an antiviral agent for hepatitis c

Details Short interfering rna as an antiviral agent for hepatitis c Short interfering rna as an antiviral agent for hepatitis c

C - Chemistry, Metallurgy

12

N

C12N 15/11 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2534991

Hepatitis C virus (HCV) is a major cause of chronic liver disease and affects over 270 million individuals worldwide. The HCV genome is a single-stranded RNA that functions as both a messenger RNA and replication template, making it an attractive target for the study of RNA interference. Double-stranded short interfering RNA (siRNA) molecules designed to target the HCV genome are disclosed herein.

Le virus de l'hépatite C (VHC) est une cause majeure de l'hépatite chronique et touche plus de 270 millions de personnes dans le monde. Le génome du VHC est un ARN simple brin qui fonctionne à la fois comme ARN messager et comme matrice de réplication, et constitue ainsi une cible intéressante pour l'étude de l'interférence de l'ARN. Des molécules de petit ARN interférant double brin (ARNsi) conçues pour cibler le génome de VHC sont également décrites.

Affiliated with

Also associated with

Rating

Short interfering rna as an antiviral agent for hepatitis c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Short interfering rna as an antiviral agent for hepatitis c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Short interfering rna as an antiviral agent for hepatitis c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1488148